skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Mostrar Somente
Refinado por: Nome da Publicação: Bmc Cancer remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Radiotherapy in bone sarcoma: the quest for better treatment option
Radiotherapy in bone sarcoma: the quest for better treatment option
Material Type:
Artigo 		Adicionar ao Meu Espaço

Radiotherapy in bone sarcoma: the quest for better treatment option

Locquet, Marie-Anaïs ; Brahmi, Mehdi ; Blay, Jean-Yves ; Dutour, Aurélie

BMC cancer, 2023-08, Vol.23 (1), p.742-742, Article 742 [Periódico revisado por pares]

England: BioMed Central Ltd

Texto completo disponível

Citações Citado por
2
Malignancy in giant cell tumor of bone: analysis of an open-label phase 2 study of denosumab
Malignancy in giant cell tumor of bone: analysis of an open-label phase 2 study of denosumab
Material Type:
Artigo 		Adicionar ao Meu Espaço

Malignancy in giant cell tumor of bone: analysis of an open-label phase 2 study of denosumab

Palmerini, Emanuela ; Seeger, Leanne L ; Gambarotti, Marco ; Righi, Alberto ; Reichardt, Peter ; Bukata, Susan ; Blay, Jean-Yves ; Dai, Tian ; Jandial, Danielle ; Picci, Piero

BMC cancer, 2021-01, Vol.21 (1), p.89-89, Article 89 [Periódico revisado por pares]

England: BioMed Central Ltd

Texto completo disponível

Citações Citado por
3
Neoadjuvant imatinib in patients with locally advanced non metastatic GIST in the prospective BFR14 trial
Neoadjuvant imatinib in patients with locally advanced non metastatic GIST in the prospective BFR14 trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Neoadjuvant imatinib in patients with locally advanced non metastatic GIST in the prospective BFR14 trial

Blesius, Aurore ; Cassier, Philippe A ; Bertucci, François ; Fayette, Jerome ; Ray-Coquard, Isabelle ; Bui, Binh ; Adenis, Antoine ; Rios, Maria ; Cupissol, Didier ; Pérol, David ; Blay, Jean-Yves ; Le Cesne, Axel

BMC cancer, 2011-02, Vol.11 (1), p.72-72, Article 72 [Periódico revisado por pares]

England: BioMed Central Ltd

Texto completo disponível

Citações Citado por
4
Outcomes from a mechanistic biomarker multi-arm and randomised study of liposomal MTP-PE
Outcomes from a mechanistic biomarker multi-arm and randomised study of liposomal MTP-PE
Material Type:
Artigo 		Adicionar ao Meu Espaço

Outcomes from a mechanistic biomarker multi-arm and randomised study of liposomal MTP-PE

Barnes, David J ; Dutton, Peter ; Bruland, Øyvind ; Gelderblom, Hans ; Faleti, Ade ; Bühnemann, Claudia ; van Maldegem, Annemiek ; Johnson, Hannah ; Poulton, Lisa ; Love, Sharon ; Tiemeier, Gesa ; van Beelen, Els ; Herbschleb, Karin ; Haddon, Caroline ; Billingham, Lucinda ; Bradley, Kevin ; Ferrari, Stefano ; Palmerini, Emanuela ; Picci, Piero ; Dirksen, Uta ; Strauss, Sandra J ; Hogendoorn, Pancras C. W ; Buddingh, Emmeline ; Blay, Jean-Yves ; Cleton-Jansen, Anne Marie ; Hassan, Andrew Bassim

BMC cancer, 2022-06, Vol.22 (1) [Periódico revisado por pares]

BioMed Central Ltd

Texto completo disponível

Citações Citado por
5
Outcome of patients with advanced solitary fibrous tumors: the Centre Léon Bérard experience
Outcome of patients with advanced solitary fibrous tumors: the Centre Léon Bérard experience
Material Type:
Artigo 		Adicionar ao Meu Espaço

Outcome of patients with advanced solitary fibrous tumors: the Centre Léon Bérard experience

Levard, Alice ; Derbel, Olfa ; Méeus, Pierre ; Ranchère, Dominique ; Ray-Coquard, Isabelle ; Blay, Jean-Yves ; Cassier, Philippe A

BMC cancer, 2013-03, Vol.13 (1), p.109-109, Article 109 [Periódico revisado por pares]

England: BioMed Central

Texto completo disponível

Citações Citado por
6
Chemotherapeutic agents attenuate CXCL12-mediated migration of colon cancer cells by selecting for CXCR4-negative cells and increasing peptidase CD26
Chemotherapeutic agents attenuate CXCL12-mediated migration of colon cancer cells by selecting for CXCR4-negative cells and increasing peptidase CD26
Material Type:
Artigo 		Adicionar ao Meu Espaço

Chemotherapeutic agents attenuate CXCL12-mediated migration of colon cancer cells by selecting for CXCR4-negative cells and increasing peptidase CD26

Cutler, Murray J ; Lowthers, Erica L ; Richard, Cynthia L ; Hajducek, Dagmar M ; Spagnuolo, Paul A ; Blay, Jonathan

BMC cancer, 2015-11, Vol.15 (879), p.882-882, Article 882 [Periódico revisado por pares]

England: BioMed Central Ltd

Texto completo disponível

Citações Citado por
7
The off-label use of targeted therapies in sarcomas: the OUTC'S program
The off-label use of targeted therapies in sarcomas: the OUTC'S program
Material Type:
Artigo 		Adicionar ao Meu Espaço

The off-label use of targeted therapies in sarcomas: the OUTC'S program

Eberst, Lauriane ; Cropet, Claire ; Le Cesne, Axel ; Pautier, Patricia ; Penel, Nicolas ; Adenis, Antoine ; Chevreau, Christine ; Bay, Jacques-Olivier ; Collard, Olivier ; Cupissol, Didier ; Duffaud, Florence ; Gentet, Jean-Claude ; Piperno-Neumann, Sophie ; Marec-Berard, Perrine ; Bompas, Emmanuelle ; Thyss, Antoine ; Chaigneau, Loic ; Cassier, Philippe ; Bertucci, François ; Blay, Jean-Yves ; Ray-Coquard, Isabelle

BMC cancer, 2014-11, Vol.14 (1), p.870-870, Article 870 [Periódico revisado por pares]

England: BioMed Central

Texto completo disponível

Citações Citado por
8
Impact of KIT exon 10 M541L allelic variant on the response to imatinib in aggressive fibromatosis: analysis of the desminib series by competitive allele specific Taqman PCR technology
Impact of KIT exon 10 M541L allelic variant on the response to imatinib in aggressive fibromatosis: analysis of the desminib series by competitive allele specific Taqman PCR technology
Material Type:
Artigo 		Adicionar ao Meu Espaço

Impact of KIT exon 10 M541L allelic variant on the response to imatinib in aggressive fibromatosis: analysis of the desminib series by competitive allele specific Taqman PCR technology

Dufresne, Armelle ; Alberti, Laurent ; Brahmi, Mehdi ; Kabani, Sarah ; Philippon, Héloïse ; Pérol, David ; Blay, Jean Yves

BMC cancer, 2014-08, Vol.14 (1), p.632-632, Article 632 [Periódico revisado por pares]

England: BioMed Central

Texto completo disponível

Citações Citado por
9
Impact of organised programs on colorectal cancer screening
Impact of organised programs on colorectal cancer screening
Material Type:
Artigo 		Adicionar ao Meu Espaço

Impact of organised programs on colorectal cancer screening

EISINGER, F ; CALS, L ; CALAZEL-BENQUE, A ; BLAY, J.Y ; COSCAS, Y ; DOLBEAULT, S

BMC cancer, 2008-04, Vol.8 (1), p.104-104, Article 104 [Periódico revisado por pares]

England: BioMed Central Ltd

Texto completo disponível

Citações Citado por
10
Germ-line mutations in epidermal growth factor receptor (EGFR) are rare but may contribute to oncogenesis: a novel germ-line mutation in EGFR detected in a patient with lung adenocarcinoma
Germ-line mutations in epidermal growth factor receptor (EGFR) are rare but may contribute to oncogenesis: a novel germ-line mutation in EGFR detected in a patient with lung adenocarcinoma
Material Type:
Artigo 		Adicionar ao Meu Espaço

Germ-line mutations in epidermal growth factor receptor (EGFR) are rare but may contribute to oncogenesis: a novel germ-line mutation in EGFR detected in a patient with lung adenocarcinoma

Centeno, Irene ; Blay, Pilar ; Santamaría, Iñigo ; Astudillo, Aurora ; Pitiot, Ana S ; Osorio, Fernando G ; González-Arriaga, Patricia ; Iglesias, Fernando ; Menéndez, Primitiva ; Tardón, Adonina ; Freije, Jose M ; Balbín, Milagros

BMC cancer, 2011-05, Vol.11 (1), p.172-172, Article 172 [Periódico revisado por pares]

England: BioMed Central Ltd

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Revistas revisadas por pares (238)

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.